Teen Adherence in KidnEy Transplant, Improving Tracking To Optimize Outcomes (Stage 1)

Summary

The overall goal of the Teen Adherence in KidnEy transplant Improving Tracking TO Optimize Outcomes (TAKE-IT TOO) study is to adapt the successful TAKE-IT intervention, aimed at improving medication adherence in adolescent kidney transplant, for use in 'real world' clinical care. The specific aims of Stage 1 of this study are: (1) To understand the needs and preferences of stakeholders (kidney transplant recipients, parents, and healthcare professionals (HCP)) in order to optimize the TAKE-IT intervention for 'real world' use.

Conditions

• Medication Adherence

Interventions

OTHER

Focus Group

Concurrently at each site, an experienced facilitator, having no direct affiliation with the clinical team, will use standardized stakeholder-specific, semi-structured scripts (designed with patient and parent collaborators) to conduct the patient, parent, and HCP focus groups. The TAKE-IT intervention will be described, and Simplemed e-pillbox shown, to all focus groups. Questions posed to the patient and parent focus groups will focus on 2 themes: the intervention and electronic monitoring. Example stakeholder-specific scripts to guide the discussions are appended. Each focus group will last \~90 min. and be audio-recorded. An observer will take field notes.

Sponsors & Collaborators

• University of Pittsburgh

  collaborator OTHER

• St. Louis Children's Hospital

  collaborator OTHER

• Seattle Children's Hospital

  collaborator OTHER

• St. Justine's Hospital

  collaborator OTHER

• The Hospital for Sick Children

  collaborator OTHER

• British Columbia Children's Hospital

  collaborator OTHER

• Temple University

  collaborator OTHER

• Université de Montréal

  collaborator OTHER

• Beth Foster

  lead OTHER

Principal Investigators

• Bethany J Foster, MD, MSCE · McGill University Health Centre/Research Institute of the McGill University Health Centre

• Annette DeVito Dabbs, PhD · University of Pittsburgh

Eligibility

Min Age

12 Years

Max Age

70 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2017-03-28

Primary Completion

2017-08-06

Completion

2017-08-06

Countries

• United States
• Canada

Study Locations